Facilitating Improvements in Kidney Health Using a Smartphone App Counseling Program in Patients With Diabetes
NCT03015480 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2019-03-01
Summary
This pilot study tests the feasibility of dietary app-supported tele-counseling in the treatment of patients with stage 1-3a chronic kidney disease (CKD) and diabetes.
Conditions
Interventions
- BEHAVIORAL
-
Remote counseling
For an 8 week period, patients will be asked to enter dietary information into the MyFitnessPal mobile application or website. Dietitians will access this information and provide personalized motivational interview phone calls on a weekly basis. After the initial 8 weeks, patients will receive a dietitian follow-up phone call around 5 and 11 months later.
Sponsors & Collaborators
- collaborator OTHER
-
Geisinger Clinic
lead OTHER
Principal Investigators
-
Alex Chang, MD · Geisinger Clinic
Study Design
- Allocation
- NA
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 21 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2017-02-13
- Primary Completion
- 2018-11-25
- Completion
- 2018-11-25
Countries
- United States
Study Locations
More Related Trials
-
Survey of Patient and Physician Awareness and Values to the Diagnosis and Treatment of Reduced Kidney Function (Chronic Kidney Disease) in Patients With High Blood Sugar Level (Type 2 Diabetes) (AWARE-CKD in T2D)
NCT04498156 ·Status: COMPLETED
-
Digital Dyadic Empowerment Program on Lifestyle Modification for Chronic Kidney Disease Management
NCT06756113 ·Status: COMPLETED ·Phase: NA
-
A Study in Participants With Diabetic Kidney Disease
NCT01113801 ·Status: TERMINATED ·Phase: PHASE2
-
Safety, Tolerability, and Feasibility of Empagliflozin Therapy in Dialysis-dependent ESKD
NCT05614115 ·Status: COMPLETED ·Phase: PHASE1
-
The Incretin Effect in Patients With Kidney Impairment
NCT01327378 ·Status: COMPLETED
-
Treating Patients With Renal Impairment and Altered Glucose MetAbolism With TherapeutIc Carbohydrate Restriction and Sglt2-Inhibiton - a Pilot Study
NCT06094231 ·Status: TERMINATED ·Phase: NA
-
Effect of Integrated CKD Care Program in Early Diabetic Nephropathy in Primary Health Care Setting.
NCT02194790 ·Status: COMPLETED ·Phase: NA
-
A Study to Assess the Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin (JNJ-28431754) in Volunteers With Varying Degrees of Kidney Function
NCT01759576 ·Status: COMPLETED ·Phase: PHASE1
-
Efficacy and Mechanisms of Dapagliflozin in Promoting Kidney Function and Cardiovascular Health in Kidney Transplant Recipients
NCT06140537 ·Status: RECRUITING ·Phase: PHASE4
-
Prediabetes in End Stage Renal Disease on Dialysis
NCT07337083 ·Status: COMPLETED
-
A Phase 2b Study of GCS-100 in Patients With Chronic Kidney Disease Caused by Diabetes
NCT02312050 ·Status: UNKNOWN ·Phase: PHASE2
-
DIALYSIS-TIR Study
NCT06042153 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Prevention of Renal Failure in People Followed for Type 2 Diabetes in General Practice
NCT05749679 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Living With CKD: An E-Learning Platform for Adolescents With CKD About the Disease and Its Management
NCT05630729 ·Status: COMPLETED ·Phase: NA
-
A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 Diabetes
NCT05901831 ·Status: COMPLETED ·Phase: PHASE3
-
A Research Study to See How Semaglutide Works Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease
NCT03819153 ·Status: COMPLETED ·Phase: PHASE3
-
Semaglutide's Effect on Renal Hemodynamics and Function in Patients With Type 2 Diabetes Mellitus and Nephropathy
NCT06555146 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
CLBS201 in Patients with Chronic Kidney Disease (CKD) and Type 2 Diabetes Mellitus (T2DM)
NCT04990427 ·Status: COMPLETED ·Phase: PHASE1
-
The Efficacy, Mechanism & Safety of Sodium Glucose Co-Transporter-2 Inhibitor & Glucagon-Like Peptide 1 Receptor Agonist Combination Therapy in Kidney Transplant Recipients
NCT05938712 ·Status: RECRUITING ·Phase: PHASE2
-
A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease
NCT04750577 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Subcutaneous Semaglutide on Kidney Transplant Candidacy
NCT04741074 ·Status: TERMINATED ·Phase: PHASE3
-
The Differential Effects of Diabetes Therapy on Inflammation
NCT02150707 ·Status: COMPLETED
-
Observational Study of Glucose Metabolism and How Dialysate Glucose Affects This
NCT02042768 ·Status: COMPLETED
-
Renal Denervation in Diabetic Nephropathy
NCT01588795 ·Status: COMPLETED ·Phase: PHASE4
-
Empagliflozin in ESKD - A Feasibility Study
NCT05687058 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1/PHASE2